Shares in 4basebio Ag (ETR:4BSB) are currently trading close to a 52 week high, with the share price up by around 5.69% to 1.97 over the past week. On a one-month basis, the 4basebio Ag price has risen by 10.2%. For investors holding t...
2INV — 2Invest AG Share Price
0.000.00%
Last Trade - 00:00FinancialsHighly SpeculativeSmall CapSuper Stock
- €76.68m
- €12.94m
- €0.07m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1.79 | 7.8 | 1.17 | 0.2 | 0.07 | 0.2 | 0.3 | -34.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for 2INV
Profile Summary
2Invest AG, formerly 4Basebio AG, is a Germany-based investment company. 2invest AG acquires, holds, manages and sells investments in corporations and partnership in the biotechnology, life science and information technologies (IT) sectors in Germany and abroad.
Directors
- Joseph Fernandez CSU
- Heikki Lanckriet CEO
- David Roth
- Pilar de la Huerta SUB
- Trevor Jarman
- Peter Llewellyn-Davies
- Timothy McCarthy (60)
- Hansjoerg Plaggemars
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- May 22nd, 1997
- Public Since
- August 10th, 2000
- No. of Employees
- 2
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- XETRA
- Shares in Issue
- 5,748,154
- Address
- Ziegelhaeuser Landstr. 3, HEIDELBERG, 69120
- Web
- https://2invest-ag.com/
- Phone
- +49 6221649240
- Auditors
- Ernst & Young GmbH
Latest News for 2INV
Upcoming events for 2INV
Q3 2021 2Invest AG Earnings Release
Similar to 2INV
MEDIQON ORD
XETRA
FAQ
What is the 2Invest AG share price?
As of Today at 11:29 UTC, shares in 2Invest AG are trading at €13.34. This share price information is delayed by 15 minutes.
How has the 2Invest AG share price performed this year?
Shares in 2Invest AG last closed at €13.34 and the price had moved by +547.57% over the past 365 days. In terms of relative price strength the 2Invest AG share price has outperformed the FTSE Global All Cap Index by +406.22% over the past year.
What are the analyst and broker recommendations for 2Invest AG?
The overall consensus recommendation for 2Invest AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the 2Invest AG dividend yield?
2Invest AG does not currently pay a dividend.
Does 2Invest AG pay a dividend?
2Invest AG does not currently pay a dividend.
When does 2Invest AG next pay dividends?
2Invest AG does not currently pay a dividend.
How do I buy 2Invest AG shares?
To buy shares in 2Invest AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of 2Invest AG?
As of the previous close price of €13.34, shares in 2Invest AG had a market capitalisation of €76.68m.
Where are 2Invest AG shares listed?
Here are the trading details for 2Invest AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: 2INV
What kind of share is 2Invest AG?
Based on an overall assessment of its quality, value and momentum 2Invest AG is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a 2Invest AG share price forecast for 2021?
The analyst consensus target price for shares in 2Invest AG is €29.70. That is 122.64% above the last closing price of €13.34.
Analysts covering 2Invest AG currently have a consensus Earnings Per Share (EPS) forecast of -€0.27 for the next financial year.
What is the trend in the 2Invest AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 2Invest AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +671.08%.
As of the last closing price of €13.34, shares in 2Invest AG were trading +68.16% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the 2Invest AG PE Ratio?
The 2Invest AG PE ratio based on its reported earnings over the past 12 months is 3.99. The shares last closed at €13.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of 2Invest AG?
2Invest AG's management team is headed by:
- Joseph Fernandez - CSU
- Heikki Lanckriet - CEO
- David Roth -
- Pilar de la Huerta - SUB
- Trevor Jarman -
- Peter Llewellyn-Davies -
- Timothy McCarthy -
- Hansjoerg Plaggemars -
Who are the major shareholders of 2Invest AG?
We do not have data on 2Invest AG's shareholders